Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

Peregrine Pharmaceuticals

Peregrine Pharmaceuticals reported $132.34M in Current Assets for its fiscal quarter ending in December of 2022.

Current Assets Change
Agenus AGEN:US USD 205.69M 7.43M
Amgen AMGN:US USD 44.7B 22.52B
AstraZeneca AZN:LN USD 22.27B 327M
Celldex Therapeutics CLDX:US USD 289.6M 28.1M
Eli Lilly LLY:US USD 20.81B 2.78B
GlaxoSmithKline GSK:LN GBP 19.72B 1.05B
Immunogen IMGN:US USD 243.86M 60.26M
Intrexon XON:US USD 137.74M 19.58M
Karyopharm Therapeutics KPTI:US USD 318.54M 37.93M
Lumos Pharma Inc. NLNK:US USD 63.25M 8.76M
MacroGenics MGNX:US USD 288.94M 66.76M
MannKind MNKD:US USD 223.3M 11.6M
Minerva Neurosciences NERV:US USD 36.67M 3.48M
Novartis NOVN:VX USD 32.11B 4.8B
Novavax NVAX:US USD 971.03M 732.36M
Peregrine Pharmaceuticals PPHM:US USD 132.34M 13.6M
Repligen RGEN:US USD 1.02B 20.68M
Roche Holding ROG:VX 33.82B 3.5B
Xencor XNCR:US USD 629.98M 45.37M